It's not always patience and luck that get patients off the organ transplant waiting list and into the operating room.
New late-breaking data presented today at ASN Kidney Week 2026 QUELIMMUNE (SCD-PED) treatment group demonstrates statistically significant higher survival in the primary analysis at Day 60, Day 90, ...
Groundwater in many areas of the U.S. and across the globe is being depleted as pumping for drinking water and agriculture ...
The Investor Relations website contains information about Ionis Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results